Athena operates in the field of human cell therapies using the latest technologies for the production of Advanced Therapy Medicines (ATMP) and point-of-care Autologous Cell Transplants.
The staff, integrating experience and know-how through an external network of scientific collaborations, produces information, training and technical solutions for specific therapeutic needs
FEATURED
Journal of Clinical Medicine | Highly Cited Papers in 2021 and 2022 from the Section “Endocrinology & Metabolism”
![](https://www.athena-med.it/wp-content/uploads/2023/08/6354.jpg)
Programs and Strategies For Limbs Preservation
Aula 6-Polo Didattico Arcispedale "Sant'Anna di Cona" Ferrara 14 Aprile 2023Medicina Rigenerativa Per i Casi Più Complicati di Chirurgia Vascolare
Sunday, April 9, 2023La Gestione delle Complicanze agli Arti Inferiori nel Diabete Mellito
Pisa, Hotel San Ranieri 20-22 Marzo 2023Piede Diabetico-Update 2022
Faculty of Medicine and Surgery, University of Rome Tor Vergata, Aula Bovet Saturday 17 December 2022![](https://www.athena-med.it/wp-content/uploads/2023/01/logo-sexton-250.png)
![](https://www.athena-med.it/wp-content/uploads/2023/02/HemaTrate-Procedure-Pack-Page.jpg)
![](https://www.athena-med.it/wp-content/uploads/2023/01/logo-symatese-250-1.png)
Events and Partecipation
Programs and Strategies For Limbs Preservation
Aula 6-Polo Didattico Arcispedale "Sant'Anna di Cona" Ferrara 14 Aprile 20231st NOTA Annual Meeting
Centro Biotecnologie Molecolari MBC Via Nizza, 52 Torino 30-31 Marzo 2023La Gestione delle Complicanze agli Arti Inferiori nel Diabete Mellito
Pisa, Hotel San Ranieri 20-22 Marzo 2023Piede Diabetico tra Innovazione e Real life
Villa Crawford, Sorrento (NA) 29 October 2022Aortic Surgery Peripheral & Venous 2022
Università Vita-Salute San Raffaele, Milano 15, 16, 17 December 2022Piede Diabetico-Update 2022
Faculty of Medicine and Surgery, University of Rome Tor Vergata, Aula Bovet Saturday 17 December 2022Athena is present with its therapeutic solutions in laboratories and in more than 40 Italian hospitals, university clinics and I.R.C.S. (Scientific Hospitalization and Treatment Institutes)
SEXTON BIOTECHNOLOGIES
Sexton Biotechnologies is a biotechnology company focused on the development and sales of bioproduction tools for cell and gene therapy, located in Indianapolis, INDIANA (USA).
Sexton develops purpose-built CGT tools and media to enable flexible automation and scaling of cell manufacturing processes to increase the probability of positive clinical outcomes and reduce time-to-market, failure points, and labor costs. Sexton’s portfolio includes the CellSeal platform of cryo-storage tools and fill/finish systems and human platelet lysate growth supplements
HemaTrate® Blood Filtration system
HemaTrate® Blood Filtration System is designed for use in the clinical laboratory, or intra-operatively at the point of care, for the rapid preparation of a total nucleated cell concentrate (TNC) from 20-120 ml of anticoagulated blood for use in human cell therapy applications.
The HemaTrate® Blood Filtration System device is contained in the HemaTrate® Procedure Pack produced by Betatex Spa on Athena specifications. HemaTrate® Procedure Pack is a sterile, assembled kit complete with required accessories for product use, supporting consistent procedural technique while considering the patient’s biological variable.
SYMATESE - NEVELIA® Bi-Layer Matrix
NEVELIA® Bi-Layer Matrix is a matrix that serves as a support (scaffold) for the infiltration of patient cells and thus contributes to the natural process of tissue regeneration. The medical grade silicone layer consists of a silicone elastomer reinforced with a polyester material, which acts as a ‘pseudo-epidermis’, protecting the wound from bacterial infection and other damage